StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ADVENZYMES.BO$381.55+0.50%
Fair $381.55+0.0%

ADVENZYMES.BO

Advanced Enzyme Technologies Limited

Basic Materials / Specialty ChemicalsBSE

$381.55

+1.90 (+0.50%)

Fairly Valued+0.0%Fair Value $381.55Fund rank 38/100 · Data gapFallback financials|
SA 65/B
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 22% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.0B · quality 81.3/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 86/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

65/100

B

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · ADVENZYMES.BOLocal privado en este navegador · Advanced Enzyme Technologies Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$42.7B

P/E

25.3x

↑

EV/EBITDA

15.3x

↑

ROE

10.3%

↑

Gross Margin

74.1%

↑

Debt/Equity

0.02

↓
52-Week Range$382
$252$420

TradingView lightweight chart

ADVENZYMES.BO price, volumen y niveles de valoración

Último $381.55Periodo +61.9%
Fair value: $381.55

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+11.3%

FCF CAGR

+0.7%

FCF margin

14.0%

FCF / Net income

0.62x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.46B · net income $1.69B · FCF $1.04B

2023-FY → 2026-FY

Gross margin

74.1%+0.5% pts

Operating margin

25.3%-0.3% pts

Net margin

22.6%+3.1% pts

FCF margin

14.0%-4.9% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$7.46B$7.46B$6.37B$6.23B$5.40B
Net Income$1.69B$1.69B$1.31B$1.33B$1.06B
EBITDA$2.75B$2.75B$2.27B$2.26B$1.78B
EPS15.0615.0611.7111.929.45
Gross Margin74.1%74.1%76.2%74.4%73.6%
Operating Margin25.3%25.3%24.8%27.7%25.6%
Net Margin22.6%22.6%20.6%21.4%19.5%
Balance Sheet
Debt/Equity0.020.020.030.040.03
Current Ratio9.789.78———
Cash Flow
Free Cash Flow$1.04B$1.04B$1.08B$940.6M$1.02B
Returns
ROE10.3%10.3%9.2%10.1%8.6%
Valuation
P/E25.3225.3223.7530.2927.28
EV/EBITDA15.2515.2513.4517.5815.86
P/B2.622.622.193.052.33
Growth & Yield
Revenue Growth17.1%17.1%2.2%15.4%—
EPS Growth28.6%28.6%-1.8%26.1%—
Dividend Yield1.4%1.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

31.0%

muy exigente

EPS terminal req.

$33.86

Spread vs growth

-2.4%

5Y implied EPS CAGR

22.2%

exigente

EPS terminal req.

$40.97

Spread vs growth

6.5%

10Y implied EPS CAGR

15.9%

exigente

EPS terminal req.

$65.98

Spread vs growth

12.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +33.6%

Total return

+33.6%

Start / end P/E

24.6x → 25.3x

EPS bridge

11.71 → 15.06

Residual

+0.8%

EPS growth+28.6%
Multiple rerating+2.8%
Dividend+1.4%
Residual / FX / buybacks / cross-term+0.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.